NM_001277115.2:c.13406G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_001277115.2(DNAH11):​c.13406G>A​(p.Arg4469Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

1
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.84

Publications

0 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
CDCA7L (HGNC:30777): (cell division cycle associated 7 like) Acts upstream of or within positive regulation of cell population proliferation. Located in cytosol; fibrillar center; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043081343).
BP6
Variant 7-21901109-G-A is Benign according to our data. Variant chr7-21901109-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 238898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00109 (166/152328) while in subpopulation AFR AF = 0.0039 (162/41570). AF 95% confidence interval is 0.00341. There are 0 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.13406G>A p.Arg4469Lys missense_variant Exon 82 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7
CDCA7LNM_018719.5 linkc.*1213C>T 3_prime_UTR_variant Exon 10 of 10 ENST00000406877.8 NP_061189.2 Q96GN5-1A0A024RA51A8K8X5
CDCA7LNM_001127370.3 linkc.*1213C>T 3_prime_UTR_variant Exon 11 of 11 NP_001120842.1 Q96GN5-4
CDCA7LNM_001127371.3 linkc.*1213C>T 3_prime_UTR_variant Exon 9 of 9 NP_001120843.1 Q96GN5-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.13406G>A p.Arg4469Lys missense_variant Exon 82 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5
CDCA7LENST00000406877.8 linkc.*1213C>T 3_prime_UTR_variant Exon 10 of 10 1 NM_018719.5 ENSP00000383986.3 Q96GN5-1

Frequencies

GnomAD3 genomes
AF:
0.00109
AC:
166
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00391
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000229
AC:
57
AN:
248996
AF XY:
0.000155
show subpopulations
Gnomad AFR exome
AF:
0.00291
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000131
AC:
191
AN:
1461680
Hom.:
0
Cov.:
33
AF XY:
0.000106
AC XY:
77
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.00418
AC:
140
AN:
33478
American (AMR)
AF:
0.000313
AC:
14
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000153
AC:
17
AN:
1111848
Other (OTH)
AF:
0.000298
AC:
18
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00109
AC:
166
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.00110
AC XY:
82
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00390
AC:
162
AN:
41570
American (AMR)
AF:
0.000196
AC:
3
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68038
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000690
Hom.:
0
Bravo
AF:
0.00118
ESP6500AA
AF:
0.00420
AC:
16
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000298
AC:
36
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jun 10, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DNAH11-related disorder Benign:1
Mar 28, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
18
DANN
Benign
0.79
DEOGEN2
Benign
0.018
.;.;T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.73
D
LIST_S2
Uncertain
0.93
D;D;D
M_CAP
Benign
0.0093
T
MetaRNN
Benign
0.0043
T;T;T
MetaSVM
Benign
-0.99
T
PhyloP100
1.8
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.71
.;N;.
REVEL
Benign
0.079
Sift
Benign
1.0
.;T;.
Vest4
0.22
MVP
0.14
ClinPred
0.020
T
GERP RS
6.0
Varity_R
0.080
gMVP
0.18
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183031009; hg19: chr7-21940727; API